EN DE
Watch Docebo Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Docebo Inc (DCBO) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Docebo Inc stock $31.87, price $28.97, upside +10.0%, quality 86 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology US · Home Canada · ISIN CA25609L1058

DI Docebo Inc logo Some data Nov 8, 2026

Docebo Inc

DCBO · US
Fairly valued, sideways

The stock costs about what our calculation considers fair.

Quality 86/100
Healthy Growth (revenue 5y +31.0 %/yr in USD)
Solidly profitable · 13.0% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (9/13)
Wide moat 75/100
Positive coverage
Fair value $31.87 · Fairly valued
Some data
Quality growth
Watch Docebo Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$92.32 $14.70 Fair Value $31.87 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range $14.70 – $92.32 · fair‑value band $19.47 – $51.40 · the $28.97 price screens below the $31.87 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Docebo in your weekly email

Every Wednesday you see whether Docebo is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Docebo Inc. develops and provides learning management platform for training in Canada, the United States, and internationally.

Show moreShow less

The company's cloud platform consists of a learning suite, which includes Docebo Learn platform, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Content Marketplace, an access to off-the-shelf learning content and provide predeveloped learning content; Insights module allows organizations to understand the results of learning programs with data visualizations; Learning Evaluation module to incorporate the learner's perspective into analyses by collection of feedback; and Advanced Analytics Pack to integrate learning data into data ecosystem and BI tool.

It also offers Communities module enabling interactive learner communities; eCommerce module that monetize from digital training contents, as well as manage and sells training offerings; eCommerce module to monetize training programs; Docebo Integrations; Headless Learning allows businesses to build learning experiences outside of the Docebo learning environment; Harmony Search, an AI-powered search capability.

In addition, the company provides Docebo Creator enables organizations to design, scale, and deploy learning contents; Docebo for Salesforce, an integration of Salesforce's APIs and technology architecture to deliver a learning experience within Salesforce workflows; Docebo Embed (OEM) enables original equipment manufacturers to embed and resell the Docebo learning platform; Docebo Branded Mobile App Publisher, allows organizations to create and distribute a branded version of Docebo's mobile learning application; Docebo Extended Enterprise supports customer education, partner enablement, and retention by enabling organizations to train external audiences from a single LMS; and Docebo for Microsoft Teams.

The company was founded in 2005 and is headquartered in Toronto, Canada.

Stock analysis

Docebo Inc (DCBO) currently trades at $28.97, while our model-based Fair Value estimate is $31.87, so the stock looks roughly fairly valued today (gap 9.1%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $70.10 per share, and 12 of the 24 models we run sit above the $28.97 price.

Bear case: the Economic Profit group reads lowest at $12.92, and 12 of the 24 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $19.47 (bear) to $51.40 (bull), the price of $28.97 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 86/100 (high quality), in the Technology sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Docebo Inc reported revenue of $243M in FY2025 versus $104M in FY2021, a compound +23.5%/yr. Reported net income was $37.5M in FY2025.

Key figures

Market cap $776M Small · P/E ratio 22.1 · P/S ratio 3.00 · EPS (TTM) $1.31 · Net margin 13.0% · Return on equity 195% · Return on assets (EBIT) 3.2% (5-year average) · Operating margin 9.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 75 out of 100 (medium confidence).

What moves the price

The share trades about 6% below its 52-week high and 97% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at 10% fair-value upside, at 10%, DCBO screens cheaper than that median.

Fair Value models

Bear $19.47 Fair Value $31.87 Bull $51.40
Price $28.97 · Upside +10.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($1.12 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $19.42 $27.22 $50.71 78
Growth DCF $18.38 $30.08 $48.52 77
EPV $10.21 $11.23 $12.08 74
All 24 models by family
DCF Models
FCF DCF $19.42 $27.22 $50.71 78
Owner Earnings $22.18 $43.30 $83.10 72
5Y Revenue Exit $14.82 $22.56 $38.69 71
5Y EBITDA Exit $18.63 $30.25 $53.02 73
5Y P/E Exit $30.24 $66.76 $116.99 67
10Y Revenue Exit $16.08 $29.39 $37.18 67
10Y EBITDA Exit $19.00 $36.97 $67.80 65
10Y P/E Exit $26.85 $60.09 $115.69 60
Earnings-Based
Graham-Dodd $10.22 $71.31 $100.07 63
Lynch FV $33.17 $47.38 $61.59 61
PEG = 1.0 $33.17 $47.38 $61.59 57
EPV $10.21 $11.23 $12.08 74
Multiples
P/E Multiple $31.58 $42.10 $52.63 63
P/S Multiple $19.17 $25.56 $31.95 58
P/B Multiple $10.54 $14.05 $17.56 55
EV/EBIT $20.44 $26.33 $32.22 66
EV/EBITDA $17.78 $22.78 $27.78 67
EV/Revenue $11.71 $15.54 $19.36 54
Asset-Based
NCAV (Graham) $0.2400 $0.3700 $0.4600 54
Growth DCF
Growth DCF $18.38 $30.08 $48.52 77
Rev-Margin DCF $15.74 $25.39 $45.10 70
Economic Profit
Residual Income $8.53 $14.61 $40.52 60
ROIC Compounder $10.21 $11.23 $12.09 72
Growth Earnings
Growth-Adj P/E $49.07 $70.10 $91.12 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 86/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 91
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 57
Do the profits arrive as real cash?
Financial strength 89
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 42
How calm the share price moves, does not count
Price momentum 64
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 69
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.0%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+42.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−12.1% (2020) → 10.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: rate outside our plausibility band
not computed

Growth Forecast

A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+15.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +12.8% a year for the price and +7.0% for the forecasts.
Forecast 2026 (sales)+13.5%
Forecast 2027 (sales)+10.1%
Projected 2028 (sales)+9.1%
Projected 2029 (sales)+8.1%
Projected 2030 (sales)+7.0%

Watch DCBO, get fair value alerts →

Recent news

News mood ⓘNews mood, the average tone of recent news (100 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.

Compare Docebo Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 628 stocks

Beats the industry median on 8/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 86 · Top 25%
Fair Value upside +10.0% · Above median
Profitability
Return on equity (12 months) 195.5% · Top 25%
Return on assets 18.2% · Top 25%
Net margin (12 months) 13.0% · Above median
Operating margin (12 months) 9.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 13.0% · Above median

Valuation Multiplesvs Software - Application median · lower = cheaper

P/E (12 months) 22.1× · Cheaper than median
P/B 10.50× · Priciest 25%
P/S (12 months) 3.00× · Pricier than median
Price / free cash flow (fiscal year) 26.7× · Pricier than median
EV/EBITDA 19.0× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)47 · sector 29
FUTURE (revenue growth)65 · sector 41
PAST (return on equity)100 · sector 20
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 29

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Adobe Inc ADBE $239.30 $463.72 +94% vs DCBO
Salesforce, Inc CRM $213.65 $342.73 +60% vs DCBO
Uber Technologies, Inc UBER $68.59 $101.28 +48% vs DCBO
Intuit Inc INTU $341.50 $459.14 +34% vs DCBO
ServiceNow, Inc NOW $101.97 $112.17 +10% vs DCBO
SAP SE SAP €210.75 €173.59 −18% vs DCBO
Cadence Design Systems, Inc CDNS $319.92 $225.48 −30% vs DCBO
Automatic Data Processing, Inc ADP $303.35 $150.40 −50% vs DCBO
Shopify Inc SHOP $148.91 $64.96 −56% vs DCBO
Snowflake Inc SNOW $275.88 $73.81 −73% vs DCBO

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Docebo Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Docebo Inc Fair Value". https://www.fairvalue-calculator.com/stock/DCBO

Frequently asked questions

Is Docebo Inc (DCBO) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of $31.87 versus a price of $28.97, about +10% upside (fairly valued).
What is the fair value of DCBO?
Our model-based fair value for Docebo Inc is $31.87 (as of Nov 8, 2026), built from audited fundamentals. The current price: $28.97.
What is the quality score of DCBO?
Docebo Inc has a Quality Score of 86/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Docebo Inc (DCBO)?
Our model-based price target is the fair value of $31.87 (as of Nov 8, 2026) from 24 valuation models. Cautious scenario $19.47, optimistic scenario $51.40. It is a calculation from audited fundamentals, not an analyst target.
What is the Docebo Inc stock forecast for 2026?
Our models put fair value at $31.87, about +10% upside versus a price of $28.97 (fairly valued). Cautious scenario $19.47, optimistic scenario $51.40. The calculation is refreshed regularly with new filings.
What is the revenue of Docebo Inc (DCBO)?
Docebo Inc reported trailing-twelve-month revenue of about $259M (latest available figure, as of Nov 8, 2026).
What growth is priced into Docebo Inc (DCBO)?
For today's price to be fair in a discounted-cash-flow model, Docebo Inc would have to grow free cash flow by +15.5 % per year for five years (discount rate 10.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +31.0 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of DCBO use?
Our models discount Docebo Inc at 10.7 %: a base by market capitalisation (small), damped by beta 0.81, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Docebo Inc that is +15.5 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.7 %) and the same formula as our fair value.
How much growth has Docebo Inc (DCBO) delivered so far?
Over the past 5 years revenue at Docebo Inc grew +31.0 % a year. The price currently implies free-cash-flow growth of +15.5 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Docebo Inc (DCBO) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Docebo Inc (+15.5 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Docebo Inc (DCBO)?
The free-cash-flow yield on the price is 3.75 %: that much free cash flow Docebo Inc produces per unit of market value. When it exceeds the discount rate of our models (10.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Docebo Inc (DCBO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Docebo Inc it is $31.87 per share (as of Nov 8, 2026), against a price of $28.97. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Docebo Inc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, DCBO trades below its calculated fair value: price $28.97, fair value $31.87, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DCBO?
No. The price is what the market pays today ($28.97); the fair value is what the company's own numbers justify ($31.87). For Docebo Inc the two are $2.90 per share apart. That gap is exactly why we show both numbers side by side.
How much is Docebo Inc worth?
The market values Docebo Inc at about $776M (market capitalisation, as of Nov 8, 2026). Per share that is $28.97; our models calculate a fair value of $31.87 per share.
What do the bullish and bearish scenarios say about DCBO?
Our models span a range for Docebo Inc: cautious scenario $19.47, base $31.87, optimistic $51.40 per share (as of Nov 8, 2026, price $28.97). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DCBO?
Docebo Inc trades at a price-to-earnings ratio of 22.1 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $31.87 is built from several models across several years. Other multiples: P/B 10.5, P/S 3.0, EV/EBITDA 19.0.
How solid is the balance sheet of Docebo Inc (DCBO)?
Balance-sheet figures for Docebo Inc (as of Nov 8, 2026): return on equity 195.5%. They feed the Quality Score of 86/100, which measures business quality independently of the share price.
How far is DCBO from its 52-week high?
Docebo Inc trades at $28.97, about 6% below its 52-week high of $30.91 and 97% above the low of $14.70 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $31.87 is for.
Which stocks are comparable to Docebo Inc?
From the same area (Technology) we also value SAP SE, Salesforce, Inc, Shopify Inc, ServiceNow, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Docebo Inc stock attractive at the current price?
The data as of Nov 8, 2026: price $28.97, calculated fair value $31.87 (+10%), Quality Score 86/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DCBO calculated?
We run Docebo Inc through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $31.87 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Docebo Inc currently trades 9% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Docebo Inc (DCBO)?
The closing price on Nov 6, 2026 was $28.97. Our model-based fair value is $31.87, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Docebo Inc right now?
The model range is unusually wide ($19.47 to $51.40). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.

Key figures of Docebo Inc

How large is the market capitalisation of Docebo Inc (DCBO)?
The market capitalisation of Docebo Inc is $776M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Docebo Inc (DCBO)?
The price-to-sales ratio of Docebo Inc is 3.00 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Docebo Inc (DCBO)?
Earnings per share at Docebo Inc are $1.31 (price ÷ EPS = P/E 22.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Docebo Inc (DCBO)?
The net margin of Docebo Inc is 13.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Docebo Inc (DCBO)?
The return on equity (ROE) of Docebo Inc is 195% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Docebo Inc (DCBO)?
On an EBIT basis the return on assets of Docebo Inc is 3.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Docebo Inc (DCBO)?
The operating margin of Docebo Inc is 9.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Docebo Inc (DCBO)?
Revenue at Docebo Inc is growing +13.0% versus a year earlier (3y avg +19.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Docebo Inc (DCBO)?
Earnings per share at Docebo Inc are growing −20.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Docebo Inc (DCBO) hold?
Docebo Inc holds more cash than debt, $69.4M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Docebo Inc in the live analysis

One click puts Docebo Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.